Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research activities to identify and optimize proprietary Twist antagonist antibodies. The antibodies will target an undisclosed checkpoint inhibitor pathway in the tumor microenvironment as potential therapeutic development candidates. Ligands in this pathway are…

Benzinga

12 Industrials Stocks Moving In Monday's Intraday Session

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

11 Information Technology Stocks Moving In Monday's Intraday Session

Benzinga

10 Financials Stocks Moving In Monday's Intraday Session

Benzinga

Jim Cramer Unimpressed By Palantir Earnings: Why He Says The Software Stock Is 'Doing So Poorly'

The overall markets continue to decline as earnings season unfolds. Monday on CNBC's "Squawk On The Street," Jim Cramer pointed out a concerning commonality among smaller companies that have reported recently.

Benzinga

Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus

Viatris Inc (NASDAQ:VTRS) reported Q1 FY22 sales of $4.18 billion, down 5% Y/Y (-1% on an operational basis), below the consensus of $4.23 billion. Brands performed better than expectations, such as Lipitor, Effexor, and Perforomist. Complex generics and biosimilars grew by 21% Y/Y on an operational basis, driven mainly by the generic…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

Benzinga

Affirm Holdings Whale Trades For May 09

A whale with a lot of money to spend has taken a noticeably bearish stance on Affirm Holdings. Looking at options history for Affirm Holdings (NASDAQ:AFRM) we detected 44 strange trades.

Benzinga

Preview: Paya Holdings's Earnings

Paya Holdings (NASDAQ:PAYA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Paya Holdings will report an earnings per share (EPS) of $0.08.

Benzinga

4 Analysts Have This to Say About Liberty Formula One Group

Liberty Formula One Group (NASDAQ:FWONK) has observed the following analyst ratings within the last quarter:

Benzinga

Lumos Pharma's Earnings: A Preview

Lumos Pharma (NASDAQ:LUMO) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Lumos Pharma will report an earnings per share (EPS) of $-0.89.

Benzinga

Earnings Outlook For Eos Energy Enterprises

Eos Energy Enterprises (NASDAQ:EOSE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Eos Energy Enterprises will report an earnings per share (EPS) of $-0.56.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Where Beacon Roofing Supply Stands With Analysts

Beacon Roofing Supply (NASDAQ:BECN) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Outlook For Exela Technologies

Exela Technologies (NASDAQ:XELA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Exela Technologies will report an earnings per share (EPS) of $-0.10.

Benzinga

Reata Pharmaceuticals Earnings Preview

Reata Pharmaceuticals (NASDAQ:RETA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Reata Pharmaceuticals will report an earnings per share (EPS) of $-2.15.

Benzinga

Earnings Preview For Atea Pharmaceuticals

Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Atea Pharmaceuticals will report an earnings per share (EPS) of $-0.58.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Krispy Kreme Debuts 'Oh, Honey! Collection' Of Doughnuts

Krispy Kreme Inc (NASDAQ: DNUT) is rolling out its latest product line with the limited edition "Oh, Honey! Collection." What Happened: According to the Charlotte, North Carolina-based company, the new collection will consist of three products:

Benzinga

How Is The Market Feeling About Palo Alto Networks?

Palo Alto Networks's (NASDAQ:PANW) short percent of float has fallen 7.3% since its last report. The company recently reported that it has 7.57 million shares sold short, which is 7.87% of all regular shares that are available for trading.

Benzinga

Why Johnson Outdoors Shares Are Plunging Today

Johnson Outdoors Inc (NASDAQ:JOUT) reported a second-quarter FY22 sales decline of 8% year-on-year to $189.62 million, missing the consensus of $202.32 million. EPS of $0.97 missed the analyst consensus of $1.85. The gross margin contracted 903 basis points Y/Y to 36.2%, primarily due to increased materials and inbound freight costs driven by supply…

Benzinga

Earnings Preview For Quanterix

Quanterix (NASDAQ:QTRX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Quanterix will report an earnings per share (EPS) of $-0.61.

Benzinga

Earnings Outlook For UroGen Pharma

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma will report an earnings per share (EPS) of $-1.33.

Benzinga

10 Analysts Have This to Say About Texas Roadhouse

Analysts have provided the following ratings for Texas Roadhouse (NASDAQ:TXRH) within the last quarter:

Benzinga

CareCloud Beats On Q1 Top and Bottomline; Reiterates FY22 Outlook

CareCloud, Inc (NASDAQ:MTBC) reported first-quarter FY22 revenue growth of 19% year-on-year to $35.3 million beating the consensus of $33.8 million. Adjusted EPS of $0.23 beat the consensus loss of $(0.27). CareCloud held $10.1 million in cash and equivalents and generated $3.1 million in operating cash flow. CareCloud reiterated the FY22 revenue outlook of…

1 … 541 542 543 544

People

Jim Cramer

508 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Eos Energy Enterprises

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.